Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT06305793Phase 2Completed
RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)
Long Coronavirus Disease 2019 (Covid19)Long COVIDLong Covid-19
StudychairStart date: 2024-05-08
NCT06305806Phase 2Completed
RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)
Long COVIDLong Covid-19
StudychairStart date: 2024-03-11

Research Network

Collaboration Network

9 collaborators·14 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Duke Clinical Research Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Cyndya Shibao, MD

Vanderbilt University Medical Center

Moderately Similar
5 trials

Shared therapeutic areas:

Post-Acute COVID-19 SyndromeLong Covid-19Long Coronavirus Disease 2019 (Covid19)

Worked with same sponsors:

Kanecia Obie Zimmerman
Collaborated on 2 trials
Similarity Score38%

Peter Novak, MD

Harvard

Moderately Similar
3 trials

Shared therapeutic areas:

Post-Acute COVID-19 SyndromeLong Covid-19Long Coronavirus Disease 2019 (Covid19)

Worked with same sponsors:

Kanecia Obie Zimmerman
Collaborated on 2 trials
Similarity Score38%

Tae Chung, MD

Johns Hopkins University

Moderately Similar
3 trials

Shared therapeutic areas:

Post-Acute COVID-19 SyndromeLong Covid-19Long Coronavirus Disease 2019 (Covid19)

Worked with same sponsors:

Kanecia Obie Zimmerman
Collaborated on 2 trials
Similarity Score38%

Pam Taub, MD

University of California, San Diego

Moderately Similar
5 trials

Shared therapeutic areas:

Post-Acute COVID-19 SyndromeLong Covid-19Long Coronavirus Disease 2019 (Covid19)

Worked with same sponsors:

Kanecia Obie Zimmerman
Collaborated on 2 trials
Similarity Score38%

Barry Make, MD

National Jewish Health

Related
4 trials

Shared therapeutic areas:

Post-Acute COVID-19 SyndromeLong Covid-19
Similarity Score20%

David Putrino, PT, PhD

Icahn School of Medicine at Mount Sinai

Related
8 trials

Shared therapeutic areas:

Long Covid-19Post-Acute COVID-19 Syndrome
Similarity Score20%

Sajad Zalzala, MD

AgelessRx

Related
6 trials

Shared therapeutic areas:

Long Covid-19Post-Acute COVID-19 Syndrome
Similarity Score20%

Leora Horwitz, MD

NYU Langone Health

Related
7 trials

Shared therapeutic areas:

Post-Acute COVID-19 SyndromeLong Covid-19
Similarity Score20%

Doris-Eva Bamiou, PhD

University College, London

Related
4 trials

Shared therapeutic areas:

Long Covid-19
Similarity Score10%

Terry L Wahls, MD

University of Iowa

Related
5 trials

Shared therapeutic areas:

Post-Acute COVID-19 Syndrome
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06305793Phase 2StudyChair

RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)

Long Coronavirus Disease 2019 (Covid19)Long COVIDLong Covid-19
Completed
NCT06305806Phase 2StudyChair

RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)

Long COVIDLong Covid-19
Completed

All 2 trials loaded